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Abstract
The recommended approach for response to severe acute respiratory syndrome 
coronavirus 2, was to test to enable timely detection, isolation and contact tracing 
so as to reduce the rapid spread of the disease. This highlighted that the laboratory 
as one of the core capacities of the International Health Regulations and key techni-
cal area in the International Health Security was critical in curbing the spread of the 
virus. Zimbabwe embarked on testing for SARS-CoV-2 in February 2020 following 
the guidance and support from WHO leveraging the existing testing capacity. 
Testing was guided by a laboratory pillar which constituted members from differ-
ent organizations partnering with the Ministry of Health and Child Care. SARS-
CoV-2 testing expansion was based on a phased approach using a tiered system in 
which laboratory staff from lower tiers were seconded to test for coronavirus using 
RT-PCR with National Microbiology Reference Laboratory (NMRL) being the hub 
for centralized consolidation of all results. As the pandemic grew nationally, there 
was an increase in testing per day and reduction in turnaround time as five labo-
ratories were fully capacitated to test using RT-PCR open platforms, thirty-three 
provincial and district laboratories to test using TB GeneXpert and 5 provincial 
laboratories to use Abbott platforms.
Keywords: pneumonia, detection, laboratory expansion, testing, partner 
coordination
1. Introduction
Coronavirus Disease 2019 (COVID-19) as it came to be known, was first 
reported as a novel pneumonia in Wuhan, China in December 2019 [1]. It was 
eventually shown to be caused by a coronavirus strain known as the severe 
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [2]. This disease was 
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declared a Public Health Emergency of International Concern by the World Health 
Organization (WHO) on 30th January 2020 and eventually a pandemic on 11 March 
2020. Africa experienced its first COVID-19 virus case on 14th February in Egypt 
[3]. This was an Italian citizen returning from Milan and had mild symptoms. South 
Africa a neighboring country to Zimbabwe had its first case confirmed on the 5th of 
March 2020 and this was also an Italian returning from Italy with mild symptoms 
identified on visiting a private general practitioner to consult for some symptoms 
[4]. Zimbabwe and other neighboring countries were at a high risk of importing 
cases and subsequent community spread of COVID-19 cases owing to the border 
trade activity with South Africa. SARS-CoV-2 presents differently among individu-
als in different population. The majority of cases in the African population present 
with asymptomatic to mild symptoms with few symptomatic cases [5]. People 
with severe forms of the disease mostly present with pneumonia and difficulty in 
breathing which may sometimes require mechanical ventilation [6]. SARS-CoV-2 
infection is spread through contact and exposure to droplets and aerosols of viral 
particles from infected persons coughing, sneezing and talking [6, 7]. Therefore, 
the main prevention method for spread is by practicing hand hygiene through 
frequent hand washing with soap or alcohol based hand sanitizer [8, 9] and use of 
face masks as guided by WHO [10]. In order to control the rate of infection, it is 
important to put in place active disease surveillance for early identification, isola-
tion and contact tracing [11, 12]. The detection of COVID-19 is largely based on the 
laboratory identification of SARS-CoV-2 virus [13, 14] hence the need to increase 
laboratory capacity for testing of suspected cases, in order to isolate cases and their 
contacts from the healthy population to reduce the spread.
The COVID -19 pandemic presented a huge demand on the laboratory compared 
to previous emergencies and at a time when most low-middle income countries were 
not well capacitated to respond to outbreaks/pandemics [14]. Laboratory being 
among the core capacities of the International Health Regulations, IHR (2005) plays 
a critical role in the timely response to emergencies [15]. Laboratory is a key techni-
cal area of International Health Security enabling countries and entities to detect 
infectious agents of human or animal origin, enhancing preparedness and response 
to infectious diseases of epidemic potential [16, 17]. Efficient diagnostic strategies 
and methods ensures timely detection of the virus [18].
Globally, SARS-COV-2 can be detected most reliably using Real-Time Polymerize 
Chain Reaction (RT- PCR), a highly sensitive molecular technique for viral nucleic 
acid detection using a number of different in-house as well as commercially avail-
able kits. Antigen and antibody based rapid diagnostic tests (RDTs) are less sensi-
tive and also used as directed by testing strategies developed by the country’s health 
regulatory authorities as recommended by WHO [19, 20].
The COVID-19 pandemic brought in a new dimension to international health 
security bringing new dimensions of solidarity [21] and selfishness in certain situa-
tions. These issues were more marked in the laboratory side of the preparedness and 
response efforts. First, to develop COVID-19 diagnostic testing, there was a need to 
share the viral material in line with the pandemic influenza preparedness plan [22] 
as well as the Nagoya Protocol [23]. This was done, according to WHO. Secondly, 
the development and distribution of diagnostics brought in a crunch with countries 
with capacity for development of these resources prioritizing themselves to the 
detriment of poorer countries with less capacity. This would then be improved 
with a solidarity movement spearheaded by WHO, which pooled organizations 
and entities involved in the response for centralized procurement and allocation of 
resources to countries in need. This saw the development of the online platform, 
COVID-19 supply portal [24] where countries could layout their requirements and 
have allocations from the global level according to their need and availability.
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Like most of the Low to middle-income countries (LMIC), Zimbabwe started 
testing for SARS-COV-2 in February 2020 without a clear strategy for testing with 
support from WHO and Africa CDC. At this point, there was one laboratory staff 
at National Microbiology Reference Laboratory (NMRL) trained at NICD in South 
Africa (facilitated by Africa CDC) on testing for COVID-19 with only 5 tests being 
done a day. The available capacity for influenza surveillance in terms of staff and 
HIV surveillance in terms of equipment and laboratory consumables became the 
initial basis for COVID-19 testing. The first case of SARS-COV-2 was detected in 
Zimbabwe on 20th of March 2020 where a male traveler of 38 years of age traveling 
from UK to Victoria Falls, had mild symptoms and tested positive for SARS-COV-2. 
At this time, there was a great need to establish a strategy to expand testing to meet 
the country’s needs before cases increased [25]. The speed at which WHO devel-
oped guidance document on the onset of the pandemic provided an opportunity for 
countries including Zimbabwe to ride on to develop their country testing strategies.
In this report, we showcase Zimbabwe’s hands on experience in scaling up 
testing for COVID-19 using RT-PCR since the start of the response in February 2020 
following a step by step tier-based approach and highlighting the major challenges 
identified along the process and key lessons learned from this experience.
2. Methodology
Zimbabwe employed a multisectoral approach through setting up dedicated 
expert committees to cover specific areas of the response based on the WHO 
guidelines on COVD-19 response preparedness [20]. In addition, a literature review 
of the available evidence was also done to understand the role of the laboratory 
in emergencies particularly of infectious diseases and how other countries have 
responded to the need to scale up laboratory capacity in order to meet the country 
needs in emergencies and outside emergencies [14, 26]. An operational plan was 
developed as well as guidelines and procedures for implementation. Coordination 
led by the MoHCC involved daily updates at the beginning reducing their frequency 
as implementation progressed. There were also weekly national coordination meet-
ings for the national taskforce who reported to the inter-ministerial committee, 
cabinet and ultimately the presidium.
2.1 Expansion of laboratory testing
One of the Joint External Evaluation (JEE) focus areas in the laboratory techni-
cal area is the presence of an effective national diagnostic network [17]. Zimbabwe 
set out to scale up laboratory capacity to test for SARS-CoV-2 leveraging existing 
capacity from other programs like influenza, HIV and TB. This expansion was 
spearheaded by the laboratory pillar in a stepwise manner as explained in the 
following sections.
2.1.1 The laboratory pillar structure establishment
The journey in the COVID-19 laboratory response in Zimbabwe began with 
establishing of the Laboratory Pillar members mandated to support scale up 
of COVID-19 testing through developing a testing strategy and supporting 
its implementation. The laboratory pillar was one of the Zimbabwe modified 
Incident Management System (IMS) guided by WHO Emergency Response 
Framework (ERF) [27] in which the Laboratory was one of the pillars in addition 
to surveillance, case management and continuity of essential services, Infection 
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prevention and control, Risk Communication and Community Engagement, 
Logistics and Points of Entry. MoHCC and partners conducted a rapid assess-
ment of the available capacity in country, leveraging existing investments in 
different programs and established a diagnostic network and infrastructure 
for COVID-19 testing. The Laboratory Pillar was led by the Directorate of 
Laboratory services (DLS) under the MoHCC and constituted of partners includ-
ing United States Centers of Disease Control and Prevention (US. CDC), World 
Health Organization (WHO), Clinton Health Access Initiative (CHAI), African 
Society of Laboratory Medicine (ASLM), the leadership from the COVID-19 
testing laboratories including the National Reference laboratories (NMRL) and 
institutions providing testing services on behalf of the MoHCC. With the pillar 
in place, a testing strategy, following the WHO guidance and recommendations 
for laboratory testing [20] was developed to guide the scale up process. The 
strategy employed a tier-based approach for expansion which activated higher 
tier laboratories followed by provincial then district. The pillar members were 
involved in the planning of this expansion which involved identifying through 
assessment and listing the laboratories with available capacity for COVID-19 
molecular testing, drafting budgets and partner commitment to support in 
particular areas of the response.
2.1.2 The scale-up of testing: the tier-based system
In March, when the first case was detected, minimal testing was being done 
by the National Microbiology Reference Laboratory (NMRL) only with a few 
staff trained to perform testing for COVID-19 virus using RT-PCR. Tier-1 of the 
expansion involved assessment of the NMRL and training of extra staff who 
would support to test for COVID-19 virus using RT-PCR and further train other 
staff during the expansion process. After successful implementation of tier-1, 
tier-2 was initiated as shown in the scale up plan in Figure 1. This involved train-
ing of more laboratory cadres and capacitating five more national level laborato-
ries to test for COVID-19 virus using RT-PCR on open PCR platforms to support 
the tier-1 laboratory. The cadres trained in tier-2 were from the laboratories listed 
during the initial planning process. The laboratories included tertiary, research 
and training laboratories namely, National Tuberculosis Reference Laboratory 
(NTBRL), National Virology Reference Laboratory (NVRL), African institute of 
Biomedical Research (AiBST), Biomedical Research Training Institute (BRTI) 
and University of Zimbabwe Clinical Trials Research Centre (UZ-CTRC). The 
inclusion criterion was based on presence of existing testing capacity based on 
availability of RT-PCR equipment and resources as well as staff experienced in 
RT-PCR. This process took a total of 3 months to complete full rollout of tier-2 
testing.
Leveraging existing TB GeneXpert platforms in the different provinces, uni-
versity Bio-labs and Mobile trucks, tier-3 was implemented through capacitating 
thirty-three provincial and district laboratories to test for COVID-19 and 5 provin-
cial laboratories to test using the Abbott platforms.
With the country experiencing a high influx of returnees from South Africa, 
there was increased risk of local transmission. This heightened the need for a robust 
surveillance strategy to minimize transmission. The country projected to test 33 
000 tests in the month of April which target was not reached as planned. This saw 
the laboratory encouraging support from private laboratories which also joined 
forces increasing testing capacity. In this line, Lancet and CIMAS laboratories 
joined in supporting to test for SARS-CoV-2 using RT-PCR to complement govern-
ment efforts to test for SARS-COV-2.
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2.1.3 Managing human resources
With the increase in samples being tested a day, it was pertinent to organize the 
flow of work to meet the workload demand. To do this, a two-shift duty system was 
introduced at every testing laboratory to increase daily throughput and reduce staff 
burnout. This extra shift system also involved separation of staff into cohorts such 
that in case of infection, quarantine and isolation procedures could be implemented 
without bringing the laboratories to a complete standstill. Additionally, locum 
staff were also hired in select laboratories to maintain adequate human resource for 
laboratory operations.
2.1.4 Quality assurance
Implementation of a new testing method for SARS-CoV-2 and use of a wide range 
of equipment, reagents, kits and consumables meant that a robust quality manage-
ment system needed to be in place. The Laboratory services leveraged existing 
Quality Management Systems (QMS) to ensure key quality system essentials were 
adapted for the new testing requirements. Given that at least 7 laboratories had ISO 
15189 accreditation, this process moved smoothly. Safety trainings were implemented 
together with waste management activities related to Guanidine thiocyanate (GITC) 
waste produced during RT-PCR testing using Abbott and GeneXpert machines. 
In addition, thirty-two laboratories were enrolled for external quality assurance 
Proficiency Testing (PT) program with Thistle, a South African PT provider as an 
external means to objectively check and ensure reliable results are being produced.
2.1.5 Data management
A robust data management system is key in the response to enable timely iden-
tification of at-risk populations, timely contact tracing and resource mobilization 
Figure 1. 
National COVID-19 Laboratory Diagnostic Preparedness Scale Up plan. Tier 1; NMRL initially carried 
out all the testing, tier 2; expanded laboratory testing to National Virology Reference Laboratory (NVRL), 
Biomedical Research and Training Institute (BRTI), National Tuberculosis Reference Laboratory (NTBRL), 
African Institute of Biomedical Science and Technology (AiBST) and UZ Clinical Trials Research Centre, tier 
3; capacitation of all provincial laboratories, University Biolabs and mobile trucks to test using GeneXpert.
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and response optimization [28]. With the increasing testing, there was a growing 
need for streamlining data management and flow to efficiently manage and report 
data. To achieve this, we leveraged on the HIV CDC-PEPFAR supported Laboratory 
Information Management System (LIMS) by introducing the COVID-19 module 
and training laboratory data staff for data entry. Fifteen testing laboratories were 
added on the LIMS allowing timely relay of results to requesting sites. To further 
reduce the data linked TAT, instant messaging system was added to the LIMS for 
automatic patient notification as soon as the results were released and published by 
the testing laboratory.
2.1.6 Resource mobilization
The beginning of the response was mostly supported through donations of test-
ing kits and supplies from China Embassy, Jack Ma foundation, Africa CDC, World 
Health Organization (WHO), Clinton Health Access Initiative (CHAI), USAID and 
many other well-wishers. The laboratory pillar members also developed a budget 
projection that specified the test expansion requirements and partners in the pillar 
committed to specific items on the budget, making the process easier. Procurement 
requests were made through the WHO global procurement platform [22] which was 
established as a hub for laboratory to support the LMIC countries in procuring these 
resources with assured equitable distribution.
2.2 Data analysis
The outcomes of this response were measured through the increase in number of 
testing laboratories which was linked to the number of samples tested per day. The 
changes in sample testing per day was analyzed using R 3.62 software.
3. Results
Through this response, Zimbabwe had an opportunity to strengthen systems 
regarding partner coordination, staff capacitation, resource mobilization, data 
management and laboratory testing output during this critical time. This response 
created and encouraged lasting coordination among the different partners on the 
laboratory pillar enabling a quick and successful scale up of testing. This coordi-
nated approach enabled capacitation of staff to test for SARS-CoV-2 while observ-
ing the necessary biosafety measures and quality assurance. Besides the increased 
knowledge in using a wide range of testing platforms, a number of scientists 
gained the skills which can be used in other instances where testing is required. 
Data management platforms have been put in place and these have strengthened 
the data handling and dissemination system. Resource mobilization was enhanced 
through the response and timely stock replenishment measures put in place. Stock 
projections were developed and monitored strictly to avoid stock-outs using a stock 
availability tracing tool. In addition, the WHO global platform [24] was established 
to support procurement of COVID-19 commodities in an equitable way. This greatly 
reduced the delays in procurement and ensured timely and equitable supply of the 
required resources through a hub. In this line, over a period of 5 months, more than 
thirty-three laboratories could perform molecular testing for COVID-19 using avail-
able PCR platforms, capacity that can be used in case of any other emergency that 
requires extensive molecular testing. With this expansion, testing increased from 
five samples a day to more than 1000 samples a day over six months. As a result of 
this collaborative effort, the target of testing 1000 samples per day was surpassed 
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in August and this exceeded the monthly projected target of 33,000 tests to 35,816 
tests that month. The number of positive samples detected also increased with 
increase in testing as shown in Figure 2. There were notable fluctuations in testing 
as seen in Figure 2 and these were due to intermittent stock outs which were due to 
the strain on the global supply that led to late delivery of commodities.
4. Discussion
The escalated and smooth scaling up of testing was made possible by leveraging 
existing capacity from other programs like Influenza Surveillance, HIV and TB 
work [29, 30]. The role of network optimsation exercises that had been done prior 
to the pandemic better placed the country to respond. The knowledge of locations 
and existing capacities and sample transport networks that had been mapped 
supported decision making in terms of activating new testing sites. However, like 
other countries, repurposing of testing laboratory facilities and consumables in 
Zimbabwe affected the HIV and TB programmes both in terms of human resources 
and consumables being repossessed for COVID-19 testing [31]. In addition, it was 
initially difficult to maintain quality management system for COVID-19 testing 
since everything operated as an emergency. At that time, there had not been proper 
planning and projecting of resources whether human resource or consumables 
which interfered with the processes. Partner coordination ensured the development 
of inter laboratory comparison panels and support sourcing of external quality 
assessment panels. Another challenge arose from the dependence on imports 
through external suppliers of all consumables which affected testing as supply chain 
Figure 2. 
Trends of samples tested and positives detected. Testing started in early March with one laboratory performing 
PCR testing. There was a marked increase in testing from April owing to the capacitation of five other labs to 
support the main reference laboratory to test using PCR. There were fluctuations owing to stock depletion due 
to the global challenge of timely delivery of reagents. Provincial laboratories were further capacitated to test 
using GeneXpert which further boosted the testing hence increasing the number of samples tested per day by 
early August.
Contemporary Developments and Perspectives in International Health Security - Volume 2
8
portals were overloaded with orders and could not meet the demand. Furthermore, 
competing with high income countries on these platforms to access in vitro diag-
nostics limited the projected rate of testing expansion. As a result like many other 
African countries [32], Zimbabwe faced a shortage in essential supply for use like 
GeneXpert supplies, PPE, molecular testing consumables and sample collecting kits 
which highly affected the testing capacity for over two months. Staff remuneration 
and motivation was also a setback throughout the participating pillars. In addition, 
some laboratory staff got infected in the course of the response which affected the 
work output and duty roster.
5. Conclusions
The laboratory is a key capacity area in International Health Security. Capacities 
to enable population access to testing of priority pathogens is key in enabling 
countries to respond to global health threats. More so the ability and agility of 
countries in finding solutions to respond to diagnostic needs of emerging novel 
infectious agents leveraging available capacities is a very important requirement 
in International Health Security. Collaboration of global and local stakeholders in 
responding to public health emergencies is key and this should be underpinned 
by a coordinated approach in addressing present and future challenges. This 
approach was key to successful implementation of processes to reduce the impact 
of COVID-19 pandemic in Zimbabwe. Working together with partners along with 
the country’s Ministry of Health and Child Care made the process of expansion 
of testing easy as this facilitated leveraging off existing government and private 
infrastructure. Strengthening of laboratory systems is crucial in the timely detec-
tion of SARS-COV-2 virus and limiting its spread. It is also important to note that 
during emergencies, the population’s need for other non-emergency laboratory tests 
remains important and should also be equally planned for in order to avoid unnec-
essary interruption of other lifesaving interventions.
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